Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Medarex and Ability Biomedical to develop fully human antibody therapeutics

Jan. 10, 2003

Phase II trial of Veronate for prevention of staph infections in premature infants under way

Jan. 9, 2003

Monoclonal antibodies targeting CD40 claimed by Kirin Brewery

Dec. 30, 2002

Novartis files NDA for Certican for prevention of kidney and heart transplant rejection

Dec. 30, 2002

TBC-MVA smallpox vaccine enters phase I testing

Dec. 30, 2002

VaxGen and Kaketsuken sign agreement for smallpox vaccine development

Dec. 27, 2002

Alliance and Mixture Sciences enter technology license agreement

Dec. 27, 2002

Shigella vaccine is safe and immunogenic in phase I trial

Dec. 27, 2002

Incell develops oral smallpox vaccine

Dec. 23, 2002

Coley receives funding to develop CpG oligos for enhancement of vaccines

Dec. 20, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...